Advanced Biomed is trading at $3.58, down 5.66% in pre-market, with no clear company-specific catalyst identified for October 21.
- Available company-news listings show no new event explaining the decline.
- Biotech and broader indexes are higher, providing no clear same-direction market explanation.
- No volume or activity-level data was provided.